Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide.
Shweta UrvaTonya QuinlanJohn LandryXiaosu MaJennifer A MartinCharles T BensonPublished in: Clinical pharmacokinetics (2022)
ClinicalTrials.gov identifier number NCT03940742.
Keyphrases